Bill
A 1838
Establishes a 17-member New Jersey Active Pharmaceutical Ingredient Regulatory Commission to oversee API manufacture, harmonize standards, and promote NJ API industry growth.
Status: PRINT NUMBER 1838B — Introduced Jan 9, 2024; most recent procedural activity Jun 3, 2025 (amend and recommit to Codes).
Primary Sponsor: Assemblyman Christopher Eachus (with multiple cosponsors).
Related/companion bills: S1161; S4922; prior-session A8140.
Important note on source materials
- The bill metadata you provided gives the title "Relates to the sale and possession of self-defense spray devices in the state."
- However, the included “Introduced Version” text in the materials is a complete and different measure that would establish the New Jersey Active Pharmaceutical Ingredient Regulatory Commission (API Commission). The official legislative status entries (print numbers, amendments) and sponsors correspond to A1838, but the content conflict means the authoritative text should be checked on the Legislature’s website. Below I summarize the actual Introduced Version provided (API commission), and then note the title discrepancy and procedural status.
Purpose and intent
- Create a New Jersey Active Pharmaceutical Ingredient Regulatory Commission to oversee standards, promote industry growth, and coordinate state/federal efforts relating to active pharmaceutical ingredient (API) manufacturing.
Key provisions and structure
- Establishes a 17-member commission located in the Executive Branch (allocated to the Department of the Treasury for constitutional purposes but independent of the department).
- Membership:
- Four public members appointed by the Governor (advice & consent of Senate) with pharmaceutical backgrounds — including at least one with API manufacturing experience.
- Two public members appointed on recommendation of the Senate President and two on recommendation of the Assembly Speaker (all with pharmaceutical or API backgrounds).
- Two State Senators and two Assembly members as ex officio, non-voting members (appointments by legislative leaders; not of the same political party).
- Commissioner of Health (or designee); Executive Director of NJEDA (or designee); Executive Director of NJ Commission on Science, Innovation and Technology (or designee).
- Two presidents of NJ public or private research institutions, appointed annually as ex officio, non-voting members.
- Terms and operations:
- Governor-appointed public members serve 5-year terms (initial staggering: three for 3 years, three for 4, three for 5).
- Members serve without compensation but may be reimbursed for necessary expenses.
- Governor designates the chair from among Governor-appointed public members.
- Commission appoints an executive director and staff with pharmaceutical backgrounds.
- Powers and duties:
- Establish standards and provide oversight of API manufacture in-state and quality/use of APIs manufactured out-of-state consistent with federal law.
- Promote growth of the API manufacturing sector in NJ; identify and help obtain federal funding/grant opportunities.
- Act as liaison between industry and state/federal governments.
- Adopt rules/regulations under the Administrative Procedure Act, adopt bylaws, maintain a seal, sue/ be sued, hold meetings/public hearings, receive/disburse non-state funds (including federal).
- Effective date: Immediately upon enactment.
Who is affected
- Pharmaceutical manufacturers (particularly API manufacturers), state regulatory bodies, research institutions, economic development stakeholders, and potentially consumers/healthcare supply chains (through impacts on API production and oversight).
Potential impact
- Centralizes state-level oversight and promotion of API manufacturing, aiming to strengthen local production capacity, quality controls, and access to federal resources. May influence economic development, supply chain resilience, and regulatory coordination with federal agencies (e.g., FDA).
If you want, I can:
- Retrieve and summarize the latest official PRINT 1838B text (if you provide it), or
- Search (if you permit external lookup) the New Jersey legislative website to confirm whether A1838 currently addresses self-defense spray devices or the API commission and then produce an updated, definitive summary.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
